Chemoradiotherapy Followed by Durvalumab in Patients With Unresectable Advanced Non‐small Cell Lung Cancer: Management of Adverse Events
Thoracic Cancer - Australia
doi 10.1111/1759-7714.13394
Full Text
Open PDFAbstract
Available in full text
Date
March 11, 2020
Authors
Publisher
Wiley